abstract |
The present invention is directed to therapeutic pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide (mepivacaine) or its pharmaceutically acceptable salts and related dosage forms for application, in a metered dose, as a film-forming liquid, to the skin, and to the use thereof for the treatment of mepivacaine responsive medical conditions such as pain and neuropathy. |